- Title
- What is the value of biomarkers for drug development in osteoarthritis?
- Creators - without role
- Martin LotzJohanne Martel-PelletierClaus ChristiansenFrancis BerenbaumMaria Luisa BrandiOlivier BruyèreRoland ChapurlatJulien ColletteCyrus CooperDick HeinegardJohn A KanisV KrausAndrea LaslopWillem LemsS LohmanderI MeulenbeltJean-Pierre PelletierJean-Pierre RaynauldSusan ReiterRené RizzoliL SandelTim SpectorWillem E Van SpilJean-Yves Reginster
- Conference
- Osteoporosis International, 24 (Suppl.1), S77-78 (2013-04); European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF), Rome, Italy [IT], du 17 Avril 2013 au 20 avril 2013
- Publisher
- Springer Science & Business Media B.V
- Identifiers
- 9951899008331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Conference proceeding
Conference proceeding
What is the value of biomarkers for drug development in osteoarthritis?
Osteoporosis International, 24 (Suppl.1), S77-78 (2013-04); European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF), Rome, Italy [IT], du 17 Avril 2013 au 20 avril 2013
04/2013
Metrics
1 Record Views